Skip to main content

Table 2 Univariate analysis results show that the risk scores are associated with a shorter OS, age, stage, and TN stage

From: Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis

 

HR

HR.95L

HR.95H

pvalue

Age

1.034418

1.017015

1.05212

P < 0.001

Gender

0.874448

0.615043

1.243263

0.454922

Grade

4.403557

0.61378

31.59327

0.140357

Stage

1.837732

1.466205

2.303401

P < 0.001

T

1.643298

1.289043

2.094909

P < 0.001

N

1.55842

1.319098

1.841162

P < 0.001

riskScore

1.853321

1.53359

2.23971

P < 0.001